The cardiovascular risk of celecoxib for knee osteoarthritis: A protocol for systematic review and meta-analysis

OBJECTIVE: The aim of this systematic review and meta-analysis is to assess the cardiovascular (CV) risk of celecoxib on knee osteoarthritis (KOA) patients compared with the risk in those prescribed other non-selective non-steroidal anti-inflammatory drugs (NSAIDs), no intervention or placebo-contro...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Shirui, Xin, Ming, Zhou, Jun, Cheng, Ying, Xu, Guixing, Zhou, Yuanfang, Li, Zhengjie, Liang, Fanrong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
6900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440337/
https://www.ncbi.nlm.nih.gov/pubmed/32358371
http://dx.doi.org/10.1097/MD.0000000000019976

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440337/
https://www.ncbi.nlm.nih.gov/pubmed/32358371
http://dx.doi.org/10.1097/MD.0000000000019976

Ejemplares similares